Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Pulmonary Hypertension, January 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 171 articles:
HTML format


 

Single Articles

  1. CHEN IC, Tan MS, Wu BN, Chai CY, et al
    Statins ameliorate pulmonary hypertension secondary to left ventricular dysfunction through the Rho-kinase pathway and NADPH oxidase.
    Pediatr Pulmonol. 2016 Dec 28. doi: 10.1002/ppul.23610.
    Abstract    

    Abstract available

  2. BERNSTEIN EJ, Gordon JK, Spiera RF, Huang WT, et al
    Comparison of change in end tidal carbon dioxide after three minutes of step exercise between systemic sclerosis patients with and without pulmonary hypertension.
    Rheumatology (Oxford). 2017;56:87-94.
    Abstract    

    Abstract available

  3. WANG L, Zhao QH, Pudasaini B, Jiang R, et al
    Clinical and Hemodynamic Characteristics of Pulmonary Hypertension associated with Interstitial Lung Disease in China.
    Clin Respir J. 2016 Dec 27. doi: 10.1111/crj.12604.
    Abstract    

    Abstract available

  4. DIVERS C, Platt D, Wang E, Lin J, et al
    A Review of Clinical Trial Endpoints of Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension and How They Relate to Patient Outcomes in the United States.
    J Manag Care Spec Pharm. 2017;23:92-104.
    Abstract    

    Abstract available

  5. RASCITI E, Sverzellati N, Silva M, Casadei A, et al
    Bronchial artery embolization for the treatment of haemoptysis in pulmonary hypertension.
    Radiol Med. 2016 Dec 26. doi: 10.1007/s11547-016-0714.
    Abstract    

    Abstract available

  6. TUDER RM
    Pulmonary vascular remodeling in pulmonary hypertension.
    Cell Tissue Res. 2016 Dec 26. doi: 10.1007/s00441-016-2539.
    Abstract    

    Abstract available

  7. GU M, Shao NY, Sa S, Li D, et al
    Patient-Specific iPSC-Derived Endothelial Cells Uncover Pathways that Protect against Pulmonary Hypertension in BMPR2 Mutation Carriers.
    Cell Stem Cell. 2016 Dec 2. pii: S1934-5909(16)30266.
    Abstract    

    Abstract available

  8. HOEPER MM, Lam CS, Vachiery JL, Bauersachs J, et al
    Pulmonary hypertension in heart failure with preserved ejection fraction: a plea for proper phenotyping and further researchdagger.
    Eur Heart J. 2016 Dec 23. pii: ehw597. doi: 10.1093.
    Abstract    



  9. ROIK M, Wretowski D, Irzyk K, Labyk A, et al
    Familial chronic thromboembolic pulmonary hypertension in a mother and a son: successful treatment with refined balloon pulmonary angioplasty.
    Pol Arch Med Wewn. 2016;126:1014-1016.
    Abstract    



  10. JIVRAJ K, Bedayat A, Sung YK, Zamanian RT, et al
    Left Atrium Maximal Axial Cross-Sectional Area is a Specific Computed Tomographic Imaging Biomarker of World Health Organization Group 2 Pulmonary Hypertension.
    J Thorac Imaging. 2016 Dec 22. doi: 10.1097/RTI.0000000000000252.
    Abstract    

    Abstract available

  11. WARD JP
    Physiological redox signalling and regulation of ion channels - implications for pulmonary hypertension.
    Exp Physiol. 2016 Dec 22. doi: 10.1113/EP086040.
    Abstract    

    Abstract available

  12. KOESTENBERGER M, Grangl G, Avian A, Gamillscheg A, et al
    Normal Reference Values and z Scores of the Pulmonary Artery Acceleration Time in Children and Its Importance for the Assessment of Pulmonary Hypertension.
    Circ Cardiovasc Imaging. 2017;10.
    Abstract    

    Abstract available

  13. MIRDAMADI A, Moshkdar P
    Benefits from the correction of vitamin D deficiency in patients with pulmonary hypertension.
    Caspian J Intern Med. 2016;7:253-259.
    Abstract    

    Abstract available

  14. HUMPL T, Berger RM, Austin ED, Fasnacht Boillat MS, et al
    Treatment initiation in paediatric pulmonary hypertension: insights from a multinational registry.
    Cardiol Young. 2016.
    Abstract    

    Abstract available

  15. RICHARDSON C, Amirtharaj C, Gruber D, Hayes DA, et al
    Assessing Myocardial Function in Infants with Pulmonary Hypertension: The Role of Tissue Doppler Imaging and Tricuspid Annular Plane Systolic Excursion.
    Pediatr Cardiol. 2016.
    Abstract    

    Abstract available

  16. XU D, Li Y, Zhang B, Wang Y, et al
    Resveratrol alleviate hypoxic pulmonary hypertension via anti-inflammation and anti-oxidant pathways in rats.
    Int J Med Sci. 2016;13:942-954.
    Abstract    

    Abstract available

  17. ZHANG A, Wang H, Wang S, Huang X, et al
    A novel mouse model of high flow-induced pulmonary hypertension-surgically induced by right pulmonary artery ligation.
    J Surg Res. 2017;208:132-139.
    Abstract    

    Abstract available

  18. AWANO N, Inomata M, Ikushima S, Yamada D, et al
    Histological analysis of vasculopathy associated with pulmonary hypertension in combined pulmonary fibrosis and emphysema: comparison with idiopathic pulmonary fibrosis and emphysema alone.
    Histopathology. 2016 Dec 19. doi: 10.1111/his.13153.
    Abstract    

    Abstract available

  19. LADOR F, Bringard A, Bengueddache S, Ferretti G, et al
    Kinetics of Cardiac Output at the Onset of Exercise in Precapillary Pulmonary Hypertension.
    Biomed Res Int. 2016;2016:6050193.
    Abstract    

    Abstract available

  20. AGUIRRE-CAMACHO A, Stepanous J, Blanco-Donoso LM, Moreno-Jimenez B, et al
    Adaptation and Validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for Use in Spain.
    Rev Esp Cardiol (Engl Ed). 2016 Dec 15. pii: S1885-5857(16)30364.
    Abstract    

    Abstract available

  21. EDWARD JA, Mandras S
    An Update on the Management of Chronic Thromboembolic Pulmonary Hypertension.
    Curr Probl Cardiol. 2017;42:7-38.
    Abstract    

    Abstract available

  22. SANDOVAL ZARATE J, Jerjes-Sanchez C, Ramirez-Rivera A, Zamudio TP, et al
    Mexican registry of pulmonary hypertension: REMEHIP (Registro Mexicano de Hipertension Pulmonar).
    Arch Cardiol Mex. 2016 Dec 14. pii: S1405-9940(16)30111.
    Abstract    

    Abstract available

  23. FITZGERALD DA, Eber E, Lands LC
    Secondary Pulmonary Hypertension: Who to consider, how to confirm and when to follow-up.
    Paediatr Respir Rev. 2016 Oct 31. pii: S1526-0542(16)30122.
    Abstract    



  24. ALTIT G, Dancea A, Renaud C, Perreault T, et al
    Pathophysiology, screening and diagnosis of pulmonary hypertension in infants with bronchopulmonary dysplasia - A review of the literature.
    Paediatr Respir Rev. 2016 Nov 9. pii: S1526-0542(16)30125.
    Abstract    

    Abstract available

  25. DOELLINGER F, Weinheimer O, Zwiener I, Mayer E, et al
    Differences of airway dimensions between patients with and without bronchiolitis obliterans syndrome after lung transplantation-Computer-assisted quantification of computed tomography.
    Eur J Radiol. 2016;85:1414-20.
    Abstract    

    Abstract available

  26. NAGASAKI J, Aoyama Y, Nomoto Y, Ido K, et al
    Reversible dasatinib-related pulmonary arterial hypertension in a CML patient.
    Rinsho Ketsueki. 2016;57:618-23.
    Abstract    

    Abstract available

  27. SCHMIDT EP, Kuebler WM, Lee WL, Downey GP, et al
    Adhesion Molecules: Master Controllers of the Circulatory System.
    Compr Physiol. 2016;6:945-73.
    Abstract    

    Abstract available

  28. SURESH K, Shimoda LA
    Lung Circulation.
    Compr Physiol. 2016;6:897-943.
    Abstract    

    Abstract available

  29. COSARDERELIOGLU C, Cosar AM, Gurakar M, Pustavoitau A, et al
    Portopulmonary Hypertension and Liver Transplant: Recent Review of the Literature.
    Exp Clin Transplant. 2016;14:113-20.
    Abstract    

    Abstract available

  30. VILLEGAS A, Arrizabalaga B, Bonanad S, Colado E, et al
    [Spanish consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria].
    Med Clin (Barc). 2016;146:278.
    Abstract    

    Abstract available

  31. GUPTA RK, Himashree G, Singh K, Soree P, et al
    Elevated pulmonary artery pressure and brain natriuretic peptide in high altitude pulmonary edema susceptible non-mountaineers.
    Sci Rep. 2016;6:21357.
    Abstract    

    Abstract available

  32. LAZZERI C, Cianchi G, Bonizzoli M, Batacchi S, et al
    The potential role and limitations of echocardiography in acute respiratory distress syndrome.
    Ther Adv Respir Dis. 2016;10:136-48.
    Abstract    

    Abstract available

  33. DYKES JC, Torres M, Alexander PJ
    Continuous inhaled iloprost in a neonate with d-transposition of the great arteries and severe pulmonary arterial hypertension.
    Cardiol Young. 2016;26:571-3.
    Abstract    

    Abstract available

  34. MADONNA R, Cocco N
    Novel Strategies in the Treatment of Pulmonary Arterial Hypertension.
    Curr Drug Targets. 2016;17:817-23.
    Abstract    

    Abstract available

  35. YAMEOGO NV, Diallo O, Kagambega LJ, Seghda A, et al
    Isolated aortic valvular and pulmonary involvement during essential eosinophilia.
    Ann Cardiol Angeiol (Paris). 2016;65:54-7.
    Abstract    

    Abstract available

  36. YUAN AH, He YY, Yang SH, Li SQ, et al
    [A novel open chest method of right ventricular hemodynamics measurement in pulmonary hypertensive mice].
    Zhonghua Xin Xue Guan Bing Za Zhi. 2016;44:1036-1039.
    Abstract    

    Abstract available

  37. WU X, Cui H, Xiao MH, Lu J, et al
    [Prevalence of pulmonary hypertension in patients with hypertrophic obstructive cardiomyopathy: a case-control study].
    Zhonghua Xin Xue Guan Bing Za Zhi. 2016;44:1010-1014.
    Abstract    

    Abstract available

  38. NOWAK J, Hudzik B, Jastrzebski D, Niedziela JT, et al
    Pulmonary hypertension in advanced lung diseases: Echocardiography as an important part of patient evaluation for lung transplantation.
    Clin Respir J. 2017 Jan 4. doi: 10.1111/crj.12608.
    Abstract    

    Abstract available

  39. METRA M
    January 2017 at a glance: oncology, diabetes and antidiabetic treatment, pulmonary hypertension.
    Eur J Heart Fail. 2017;19:7-8.
    Abstract    



  40. LAMELA DOMENECH AE, Lopez-Candales A
    Is the Electrocardiogram Still Useful in Detecting Right Ventricular Abnormalities in Patients with Pulmonary Hypertension when Compared to Echocardiography?
    Clin Respir J. 2017 Jan 4. doi: 10.1111/crj.12607.
    Abstract    



  41. OZTURK S, Kalyoncuoglu M, Durmus G, Topcu A, et al
    Case images: Pulmonary hypertension due to left upper lobe partial anomalous pulmonary venous return.
    Turk Kardiyol Dern Ars. 2016;44:717.
    Abstract    



  42. NOWROOZPOOR A, Hshemian SM, Malekmohammad M, Marjani M, et al
    Usefulness of pulmonary artery diameter in diagnosing pulmonary hypertension in patients admitted to tuberculosis intensive care unit.
    Int J Mycobacteriol. 2016;5 Suppl 1:S56.
    Abstract    

    Abstract available

  43. ALNEMRI AM
    Black lung persistent pulmonary hypertension of the newborn. Saudi experience with sildenafil and nitric oxide.
    Saudi Med J. 2017;38:97-100.
    Abstract    

    Abstract available

  44. IVARSSON B, Radegran G, Hesselstrand R, Kjellstrom B, et al
    Information, social support and coping in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension-A nationwide population-based study.
    Patient Educ Couns. 2016 Dec 21. pii: S0738-3991(16)30573.
    Abstract    

    Abstract available

  45. NOGUEIRA-FERREIRA R, Ferreira-Pinto MJ, Silva AF, Vitorino R, et al
    HMGB1 Down-Regulation Mediates Terameprocol Vascular Anti-Proliferative Effect in Experimental Pulmonary Hypertension.
    J Cell Physiol. 2016 Dec 30. doi: 10.1002/jcp.25763.
    Abstract    

    Abstract available

  46. OGO T, Fukuda T, Tsuji A, Fukui S, et al
    Efficacy and safety of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension guided by cone-beam computed tomography and electrocardiogram-gated area detector computed tomography.
    Eur J Radiol. 2016 Dec 21. pii: S0720-048X(16)30407.
    Abstract    

    Abstract available


  47. You're the Flight Surgeon.
    Aerosp Med Hum Perform. 2016;87:833-5.
    Abstract    

    Abstract available

  48. YAO H, Zhou D, Kong D, Pan C, et al
    New echocardiographic indexes for evaluating cardiac function in idiopathic pulmonary arterial hypertension using three-dimensional echocardiography.
    Acta Cardiol. 2016;71:359-66.
    Abstract    



  49. AVDEEV SN
    [The new endothelin receptor antagonist macitentan: Prospects for therapy of pulmonary arterial hypertension].
    Ter Arkh. 2016;88:89-97.
    Abstract    

    Abstract available

  50. VINCZE K, Odler B, Muller V
    [Pulmonary manifestations in systemic lupus erythematosus].
    Orv Hetil. 2016;157:1154-60.
    Abstract    

    Abstract available

  51. LAKATOS B, Kovacs A, Tokodi M, Doronina A, et al
    [Assessment of the right ventricular anatomy and function by advanced echocardiography: pathological and physiological insights].
    Orv Hetil. 2016;157:1139-46.
    Abstract    

    Abstract available

  52. FUJI S, Matsushita S, Hyodo K, Osaka M, et al
    Association between endothelial function and micro-vascular remodeling measured by synchrotron radiation pulmonary micro-angiography in pulmonary arterial hypertension.
    Gen Thorac Cardiovasc Surg. 2016;64:597-603.
    Abstract    

    Abstract available

  53. SUEN CM, Zhai A, Lalu MM, Welsh C, et al
    Efficacy and safety of regenerative cell therapy for pulmonary arterial hypertension in animal models: a preclinical systematic review protocol.
    Syst Rev. 2016;5:89.
    Abstract    

    Abstract available

  54. LI XW, Lin YZ, Lin H, Huang JB, et al
    Histidine-tryptophan-ketoglutarate solution decreases mortality and morbidity in high-risk patients with severe pulmonary arterial hypertension associated with complex congenital heart disease: an 11-year experience from a single institution.
    Braz J Med Biol Res. 2016;49:e5208.
    Abstract    

    Abstract available

  55. GEORGE MP, Singh V, Gladwin MT
    Noninfectious and Nonneoplastic Conditions Associated with Human Immunodeficiency Virus Infection.
    Semin Respir Crit Care Med. 2016;37:289-302.
    Abstract    

    Abstract available

  56. LI L, Zhang X, Li X, Lv C, et al
    TGF-beta1 inhibits the apoptosis of pulmonary arterial smooth muscle cells and contributes to pulmonary vascular medial thickening via the PI3K/Akt pathway.
    Mol Med Rep. 2016;13:2751-6.
    Abstract    

    Abstract available

  57. NGUYEN KL, Tian X, Alam S, Mehari A, et al
    Elevated transpulmonary gradient and cardiac magnetic resonance-derived right ventricular remodeling predict poor outcomes in sickle cell disease.
    Haematologica. 2016;101:e40-3.
    Abstract    



  58. ABRAHAM D, Freeman LJ, Lewis C, O'Sullivan M, et al
    Coronary artery disease in Eisenmenger's syndrome--Rare but not to be forgotten.
    Int J Cardiol. 2016;203:276-7.
    Abstract    



  59. ROSENKRANZ S, Gibbs JS, Wachter R, De Marco T, et al
    Left ventricular heart failure and pulmonary hypertensiondagger.
    Eur Heart J. 2015.
    Abstract    

    Abstract available

  60. MATURA LA, McDonough A, Carroll DL
    Symptom Interference Severity and Health-Related Quality of Life in Pulmonary Arterial Hypertension.
    J Pain Symptom Manage. 2016;51:25-32.
    Abstract    

    Abstract available

  61. KELLY NJ, Radder JE, Baust JJ, Burton CL, et al
    Mouse Genome-wide Association Study of Pre-clinical Group II Pulmonary Hypertension Identifies Egfr.
    Am J Respir Cell Mol Biol. 2017 Jan 13. doi: 10.1165/rcmb.2016-0176.
    Abstract    

    Abstract available

  62. MIRSAEIDI M, Omar HR, Baughman R, Machado R, et al
    The association between BNP, 6MWD test, DLCO% and pulmonary hypertension in sarcoidosis.
    Sarcoidosis Vasc Diffuse Lung Dis. 2016;33:317-320.
    Abstract    

    Abstract available

  63. BAUFRETON C, Bruneval P, Rousselet MC, Ennezat PV, et al
    Fatal postoperative systemic pulmonary hypertension in benfluorex-induced valvular heart disease surgery: A case report.
    Medicine (Baltimore). 2017;96:e4985.
    Abstract    

    Abstract available

  64. JIA D, Zhu Q, Liu H, Zuo C, et al
    Osteoprotegerin Disruption Attenuates HySu-Induced Pulmonary Hypertension Through Integrin alphavbeta3/FAK/AKT Pathway Suppression.
    Circ Cardiovasc Genet. 2017;10.
    Abstract    

    Abstract available

  65. VAN TOSH A, Nichols KJ
    Pharmacologic stress myocardial perfusion imaging in patients with pulmonary hypertension: What do we know, and what remains to be learned?
    J Nucl Cardiol. 2017 Jan 10. doi: 10.1007/s12350-016-0771.
    Abstract    



  66. ENDE-VERHAAR YM, Huisman MV, Klok FA
    To screen or not to screen for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism.
    Thromb Res. 2017;151:1-7.
    Abstract    

    Abstract available

  67. KAMIJIMA R, Suzuki K, Izumo M, Kuwata S, et al
    Predictors of Exercise-Induced Pulmonary Hypertension in Patients with Asymptomatic Degenerative Mitral Regurgitation: Mechanistic Insights from 2D Speckle-Tracking Echocardiography.
    Sci Rep. 2017;7:40008.
    Abstract    

    Abstract available

  68. MATHEW R, Huang J, Wu JM, Fallon JT, et al
    Hematological disorders and pulmonary hypertension.
    World J Cardiol. 2016;8:703-718.
    Abstract    

    Abstract available

  69. KUEBLER WM
    What mediates the effects of thrombospondin-1 in pulmonary hypertension? New evidence for a dual-pronged role of CD47.
    Cardiovasc Res. 2017;113:3-5.
    Abstract    



  70. PITTMAN C, Hsieh MM, Coles W, Tisdale JF, et al
    Reversal of pre-capillary pulmonary hypertension in a patient with sickle cell anemia who underwent haploidentical peripheral blood stem cell transplantation.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    Abstract    



  71. NAGAO M, Yamasaki Y, Abe K, Hosokawa K, et al
    Energy efficiency and pulmonary artery flow after balloon pulmonary angioplasty for inoperable, chronic thromboembolic pulmonary hypertension: Analysis by phase-contrast MRI.
    Eur J Radiol. 2017;87:99-104.
    Abstract    

    Abstract available

  72. SHUJAAT A, Bajwa AA, Al-Saffar F, Bellardini J, et al
    Diagnostic accuracy of echocardiography combined with chest CT in pulmonary hypertension.
    Clin Respir J. 2017 Jan 7. doi: 10.1111/crj.12610.
    Abstract    

    Abstract available

  73. ROBINSON JC, Abbott C, Meadows CA, Roach RC, et al
    Long-Term Health Outcomes in High-Altitude Pulmonary Hypertension.
    High Alt Med Biol. 2017 Jan 6. doi: 10.1089/ham.2016.0098.
    Abstract    

    Abstract available

  74. RENAPURKAR RD, Shrikanthan S, Heresi GA, Lau CT, et al
    Imaging in Chronic Thromboembolic Pulmonary Hypertension.
    J Thorac Imaging. 2017 Jan 2. doi: 10.1097/RTI.0000000000000256.
    Abstract    

    Abstract available

  75. COLVIN KL, Ivy DD, Yeager ME
    Altered Peripheral Blood Myeloid Cell Subpopulations in Children With Down Syndrome and Pulmonary Hypertension.
    J Pediatr Hematol Oncol. 2017 Jan 5. doi: 10.1097/MPH.0000000000000727.
    Abstract    



  76. JAMAL N, Rajhy M, Bapumia M
    Painless acute myocardial infarction on Mount Kilimanjaro.
    BMJ Case Rep. 2016;2016.
    Abstract    

    Abstract available

  77. ARYAN Z, Modaresi M
    Paediatric orphan lung diseases in Asia.
    Lancet Respir Med. 2016;4:174-5.
    Abstract    



  78. HILDE JM, Skjorten I, Hansteen V, Melsom MN, et al
    Assessment of Right Ventricular Afterload in COPD.
    COPD. 2016;13:176-85.
    Abstract    

    Abstract available

  79. POUSADA G, Baloira A, Castro-Anon O, Valverde D, et al
    [Pulmonary arterial hypertension associated with human immunodeficiency virus infection: study of 4 cases].
    Med Clin (Barc). 2016;146:350-3.
    Abstract    

    Abstract available

  80. EVANS JD, Girerd B, Montani D, Wang XJ, et al
    BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis.
    Lancet Respir Med. 2016 Jan 18. pii: S2213-2600(15)00544.
    Abstract    

    Abstract available

  81. RICE KM, Manne ND, Kolli MB, Wehner PS, et al
    Curcumin nanoparticles attenuate cardiac remodeling due to pulmonary arterial hypertension.
    Artif Cells Nanomed Biotechnol. 2016;44:1909-1916.
    Abstract    

    Abstract available

  82. DUIJNHOUWER AL, Navarese EP, Van Dijk AP, Loeys B, et al
    Aneurysm of the Pulmonary Artery, a Systematic Review and Critical Analysis of Current Literature.
    Congenit Heart Dis. 2016;11:102-9.
    Abstract    

    Abstract available

  83. HAYES DA
    Constriction of the ductus arteriosus, severe right ventricular hypertension, and a right ventricular aneurysm in a fetus after maternal use of a topical treatment for striae gravidarum.
    Cardiol Young. 2016;26:796-8.
    Abstract    

    Abstract available

  84. ZHANG LL, Lu J, Li MT, Wang Q, et al
    Preventive and remedial application of etanercept attenuate monocrotaline-induced pulmonary arterial hypertension.
    Int J Rheum Dis. 2016;19:192-8.
    Abstract    

    Abstract available

  85. MAEDER MT, Schoch OD, Kleiner R, Joerg L, et al
    Pulmonary hypertension associated with left-sided heart disease.
    Swiss Med Wkly. 2017;147:w14395.
    Abstract    

    Abstract available

  86. WU XT, Chen YQ, Lu WJ
    [Role of pulmonary vein in pulmonary hypertension].
    Zhonghua Jie He He Hu Xi Za Zhi. 2017;40:68-70.
    Abstract    



  87. CHEN RK, Hong C, Zhou YM, Kuang AL, et al
    [Severe obstructive sleep apnea-hypopnea syndrome with dilated cardiomyopathy leading to pulmonary hypertension: case report and literature review].
    Zhonghua Jie He He Hu Xi Za Zhi. 2017;40:46-51.
    Abstract    

    Abstract available

  88. SHI X, Yang GL, Chen Y, Guo J, et al
    [End tidal PCO(2) for evaluation of severity of disease in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension].
    Zhonghua Jie He He Hu Xi Za Zhi. 2017;40:34-39.
    Abstract    

    Abstract available

  89. WANG L, Wu HY, Li MX
    [Protective effects of heat shock protein 70 against hypoxic pulmonary hypertension in neonatal rats].
    Zhongguo Dang Dai Er Ke Za Zhi. 2017;19:88-94.
    Abstract    

    Abstract available

  90. MORRIS NR, Kermeen FD, Holland AE
    Exercise-based rehabilitation programmes for pulmonary hypertension.
    Cochrane Database Syst Rev. 2017;1:CD011285.
    Abstract    

    Abstract available

  91. GIACCONE A, Zuppa AF, Sood B, Cohen MS, et al
    Milrinone Pharmacokinetics and Pharmacodynamics in Neonates with Persistent Pulmonary Hypertension of the Newborn.
    Am J Perinatol. 2017 Jan 18. doi: 10.1055/s-0036-1597996.
    Abstract    

    Abstract available

  92. MAARMAN GJ, Schulz R, Sliwa K, Schermuly R, et al
    Novel putative pharmacologic therapies to protect the right ventricle in pulmonary hypertension: A review of current literature.
    Br J Pharmacol. 2017 Jan 18. doi: 10.1111/bph.13721.
    Abstract    

    Abstract available

  93. VAN DER LEE R, Peels B, Koopman-Esseboom C
    PDE3 inhibition with enoximone as first-line therapy for severe persistent pulmonary hypertension of the newborn during neonatal transport: a case report.
    Clin Case Rep. 2016;5:18-21.
    Abstract    

    Abstract available

  94. MANUEL DA, Ghosh GC, Alex AG
    Atrial septal defect with right-to-left shunt in the absence of pulmonary hypertension.
    Cardiol Young. 2017 Jan 17:1-2. doi: 10.1017/S1047951116002754.
    Abstract    

    Abstract available

  95. DAWES TJ, de Marvao A, Shi W, Fletcher T, et al
    Machine Learning of Three-dimensional Right Ventricular Motion Enables Outcome Prediction in Pulmonary Hypertension: A Cardiac MR Imaging Study.
    Radiology. 2017 Jan 16:161315. doi: 10.1148/radiol.2016161315.
    Abstract    

    Abstract available

  96. BANDORSKI D, Bogossian H, Stempfl J, Seeger W, et al
    Prognostic Relevance of Nonsustained Ventricular Tachycardia in Patients with Pulmonary Hypertension.
    Biomed Res Int. 2016;2016:1327265.
    Abstract    

    Abstract available

  97. FRUMP AL, Datta A, Ghose S, West J, et al
    Genotype-phenotype effects of Bmpr2 mutations on disease severity in mouse models of pulmonary hypertension.
    Pulm Circ. 2016;6:597-607.
    Abstract    

    Abstract available

  98. FORD HJ, Baughman RP, Aris R, Engel P, et al
    Tadalafil therapy for sarcoidosis-associated pulmonary hypertension.
    Pulm Circ. 2016;6:557-562.
    Abstract    

    Abstract available

  99. SATO T, Tsujino I, Sugimoto A, Nakaya T, et al
    The effects of pulmonary vasodilating agents on right ventricular parameters in severe group 3 pulmonary hypertension: a pilot study.
    Pulm Circ. 2016;6:524-531.
    Abstract    

    Abstract available

  100. GALL H, Preston IR, Hinzmann B, Heinz S, et al
    An international physician survey of chronic thromboembolic pulmonary hypertension management.
    Pulm Circ. 2016;6:472-482.
    Abstract    

    Abstract available

  101. SINGLA S, Zhou T, Javaid K, Abbasi T, et al
    Expression profiling elucidates a molecular gene signature for pulmonary hypertension in sarcoidosis.
    Pulm Circ. 2016;6:465-471.
    Abstract    

    Abstract available

  102. PULLAMSETTI SS, Perros F, Chelladurai P, Yuan J, et al
    Transcription factors, transcriptional coregulators, and epigenetic modulation in the control of pulmonary vascular cell phenotype: therapeutic implications for pulmonary hypertension (2015 Grover Conference series).
    Pulm Circ. 2016;6:448-464.
    Abstract    

    Abstract available

  103. BARNES JW, Tonelli AR, Heresi GA, Newman JE, et al
    Novel methods in pulmonary hypertension phenotyping in the age of precision medicine (2015 Grover Conference series).
    Pulm Circ. 2016;6:439-447.
    Abstract    

    Abstract available

  104. SON JW
    Early Detection for Right Ventricular Dysfunction in Bronchopulmonary Dysplasia without Pulmonary Hypertension.
    J Cardiovasc Ultrasound. 2016;24:268-269.
    Abstract    



  105. ZERIOUH M, Zych B, Sabashnikov A, Weymann A, et al
    Combined Lung Transplantation and Extraction of a Misplaced Superior Vena Cava Stent From the Right Ventricle.
    Artif Organs. 2016;40:1150-1151.
    Abstract    



  106. SOMEYA F, Mugii N, Oohata S
    Factors relating to impaired stroke volume during the 6-minute walk test in patients with systemic sclerosis.
    Clin Exp Rheumatol. 2016;34 Suppl 100:152-156.
    Abstract    

    Abstract available

  107. THAKKAR V, Stevens W, Prior D, Rabusa C, et al
    The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.
    Clin Exp Rheumatol. 2016;34 Suppl 100:129-136.
    Abstract    

    Abstract available

  108. KEATING GM
    Macitentan: A Review in Pulmonary Arterial Hypertension.
    Am J Cardiovasc Drugs. 2016;16:453-460.
    Abstract    

    Abstract available

  109. FLESHNER M, Olivier KN, Shaw PA, Adjemian J, et al
    Mortality among patients with pulmonary non-tuberculous mycobacteria disease.
    Int J Tuberc Lung Dis. 2016;20:582-7.
    Abstract    

    Abstract available

  110. MOHAMED NA, Ahmetaj-Shala B, Duluc L, Mackenzie LS, et al
    A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension.
    J Cardiovasc Transl Res. 2016;9:162-4.
    Abstract    

    Abstract available

  111. BOZBAS SS, Bozbas H
    Portopulmonary hypertension in liver transplant candidates.
    World J Gastroenterol. 2016;22:2024-9.
    Abstract    

    Abstract available

  112. MARTINEZ-SELLES M, Lambert Rodriguez JL, Barrios V, Diez-Villanueva P, et al
    Clinical Cardiology, Geriatric Cardiology, Heart Failure, and Transplantation 2015: A Selection of Topical Issues.
    Rev Esp Cardiol (Engl Ed). 2016;69:159-66.
    Abstract    



  113. PARK SY, Lee SM, Shin JW, Choi BW, et al
    Epidemiology of chronic thromboembolic pulmonary hypertension in Korea: results from the Korean registry.
    Korean J Intern Med. 2016;31:305-12.
    Abstract    

    Abstract available

  114. ARYA B, Kerstein D, Leu CS, Hayes D, et al
    Echocardiographic Assessment of Right Atrial Pressure in a Pediatric and Young Adult Population.
    Pediatr Cardiol. 2016;37:558-67.
    Abstract    

    Abstract available

  115. AVERIN K, Michelfelder E, Sticka J, Cash M, et al
    Changes in Ventricular Geometry Predict Severity of Right Ventricular Hypertension.
    Pediatr Cardiol. 2016;37:575-81.
    Abstract    

    Abstract available

  116. VELAZQUEZ MARTIN M, Albarran Gonzalez-Trevilla A, Jimenez Lopez-Guarch C, Garcia Tejada J, et al
    Use of Atrial Septostomy to Treat Severe Pulmonary Arterial Hypertension in Adults.
    Rev Esp Cardiol (Engl Ed). 2016;69:78-81.
    Abstract    



  117. VERSLUYS AB, Bresters D
    Pulmonary Complications of Childhood Cancer Treatment.
    Paediatr Respir Rev. 2016;17:63-70.
    Abstract    

    Abstract available

  118. MERIDETH FL, Quinn DK
    "Walking the Walk": Decisional Capacity Deficits After Right Hemisphere Subdural Hematoma.
    Psychosomatics. 2016;57:102-6.
    Abstract    



  119. KANDHI S, Froogh G, Qin J, Luo M, et al
    EETs Elicit Direct Increases in Pulmonary Arterial Pressure in Mice.
    Am J Hypertens. 2016;29:598-604.
    Abstract    

    Abstract available

  120. GUVENC TS, Huseyinoglu N, Ozben S, Kul S, et al
    Right ventricular geometry and mechanics in patients with obstructive sleep apnea living at high altitude.
    Sleep Breath. 2016;20:5-13.
    Abstract    

    Abstract available

  121. WEIR NA, Saiyed R, Alam S, Conrey A, et al
    Prostacyclin-analog therapy in sickle cell pulmonary hypertension.
    Haematologica. 2017 Jan 25. pii: haematol.2015.131227.
    Abstract    

    Abstract available

  122. ZOLTY R
    Pulmonary Hypertension in Left Ventricular Dysfunction: Still Numerous Unanswered Questions.
    J Card Fail. 2017 Jan 23. pii: S1071-9164(17)30030.
    Abstract    



  123. AMSELLEM V, Abid S, Poupel L, Parpaleix A, et al
    Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2017 Jan 26. doi: 10.1165/rcmb.2016-0201.
    Abstract    

    Abstract available

  124. AMSALLEM M, Boulate D, Kooreman Z, Zamanian RT, et al
    Investigating the value of right heart echocardiographic metrics for detection of pulmonary hypertension in patients with advanced lung disease.
    Int J Cardiovasc Imaging. 2017 Jan 24. doi: 10.1007/s10554-017-1069.
    Abstract    

    Abstract available

  125. MENG Q, Lai YC, Kelly NJ, Bueno M, et al
    Development of a Mouse Model of Metabolic Syndrome, Pulmonary Hypertension, and Heart Failure with Preserved Ejection Fraction (PH-HFpEF).
    Am J Respir Cell Mol Biol. 2017 Jan 24. doi: 10.1165/rcmb.2016-0177.
    Abstract    

    Abstract available

  126. WU J, Jia J, Liu L, Yang F, et al
    Schisandrin B displays a protective role against primary pulmonary hypertension by targeting transforming growth factor beta1.
    J Am Soc Hypertens. 2016 Dec 28. pii: S1933-1711(16)30606.
    Abstract    

    Abstract available

  127. PLACIDO R, Cortez-Dias N, Robalo Martins S, Gomes Almeida A, et al
    Prognostic stratification in pulmonary hypertension: A multi-biomarker approach.
    Rev Port Cardiol. 2017 Jan 21. pii: S0870-2551(16)30215.
    Abstract    

    Abstract available

  128. SCIUME M, Mattiello V, Cattaneo D, Bucelli C, et al
    Early Detection of Pulmonary Hypertension in Primary Myelofibrosis: The role of Echocardiography, Cardiopulmonary Exercise Testing and Biomarkers.
    Am J Hematol. 2017 Jan 21. doi: 10.1002/ajh.24656.
    Abstract    



  129. FENG Z, Dong L, Cao J, Bai J, et al
    A case study of ciliary detachment with primary pulmonary hypertension.
    Int Ophthalmol. 2017 Jan 21. doi: 10.1007/s10792-017-0443.
    Abstract    

    Abstract available

  130. DUGGAN ST, Keam SJ, Burness CB
    Selexipag: A Review in Pulmonary Arterial Hypertension.
    Am J Cardiovasc Drugs. 2017;17:73-80.
    Abstract    

    Abstract available

  131. TASLAKIAN B, Latson LA, Truong MT, Aaltonen E, et al
    CT pulmonary angiography of adult pulmonary vascular diseases: Technical considerations and interpretive pitfalls.
    Eur J Radiol. 2016;85:2049-2063.
    Abstract    

    Abstract available

  132. MATTAR MM, Morad MA, El Husseiny NM, Ali NH, et al
    Correlation between JAK2 allele burden and pulmonary arterial hypertension and hematological parameters in Philadelphia negative JAK2 positive myeloproliferative neoplasms. An Egyptian experience.
    Ann Hematol. 2016;95:1611-6.
    Abstract    

    Abstract available

  133. STENSON B
    Highlights from this issue.
    Arch Dis Child Fetal Neonatal Ed. 2016;101:F279.
    Abstract    



  134. WANG P, Xu J, Hou Z, Wang F, et al
    miRNA-34a promotes proliferation of human pulmonary artery smooth muscle cells by targeting PDGFRA.
    Cell Prolif. 2016;49:484-93.
    Abstract    

    Abstract available

  135. SUN M, Li HX, Xie YF, Xu H, et al
    [Outcomes after singleversus bilateral lung transplantation for idiopathic pulmonary fibrosis].
    Zhonghua Jie He He Hu Xi Za Zhi. 2016;39:444-9.
    Abstract    

    Abstract available

  136. VELAYATI A, Valerio MG, Shen M, Tariq S, et al
    Update on pulmonary arterial hypertension pharmacotherapy.
    Postgrad Med. 2016;128:460-73.
    Abstract    

    Abstract available

  137. ALI Z, Waseem M, Kumar R, Pandey P, et al
    Unveiling the interactions among BMPR-2, ALK-1 and 5-HTT genes in the pathophysiology of HAPE.
    Gene. 2016;588:163-72.
    Abstract    

    Abstract available

  138. GUILLEMINAULT L, Laurent S, Foucher A, Poubeau P, et al
    Pulmonary arterial hypertension in adult onset Still's disease: a case report of a severe complication.
    BMC Pulm Med. 2016;16:72.
    Abstract    

    Abstract available

  139. NOSE T, Kondo M, Shimizu M, Hamura H, et al
    Pharmacological Profile of GPD-1116, an Inhibitor of Phosphodiesterase 4.
    Biol Pharm Bull. 2016;39:689-98.
    Abstract    

    Abstract available

  140. ATAYA A, Patel S, Cope J, Alnuaimat H, et al
    Pulmonary arterial hypertension and associated conditions.
    Dis Mon. 2016;62:379-402.
    Abstract    



  141. AHMED M, Dweik RA, Tonelli AR
    What is the best approach to a high systolic pulmonary artery pressure on echocardiography?
    Cleve Clin J Med. 2016;83:256-60.
    Abstract    



  142. LEIKIN JB
    Foreword.
    Dis Mon. 2016;62:378.
    Abstract    



  143. BAXI AJ, Restrepo CS, Vargas D, Marmol-Velez A, et al
    Hypertrophic Cardiomyopathy from A to Z: Genetics, Pathophysiology, Imaging, and Management.
    Radiographics. 2016;36:335-54.
    Abstract    

    Abstract available

  144. WANG X, Ibrahim YF, Das D, Zungu-Edmondson M, et al
    Carfilzomib reverses pulmonary arterial hypertension.
    Cardiovasc Res. 2016;110:188-99.
    Abstract    

    Abstract available

  145. DELLA ROSSA A, D'Ascanio A, Barsotti S, Stagnaro C, et al
    Post-occlusive reactive hyperaemia (POHR) in systemic sclerosis: very early disease (VEDOSS) represents a separate entity compared to established disease.
    Scand J Rheumatol. 2016;45:408-11.
    Abstract    

    Abstract available

  146. TANEL RE
    ECGs in the ED.
    Pediatr Emerg Care. 2016;32:202-3.
    Abstract    



  147. VOILLIOT D, Magne J, Dulgheru R, Kou S, et al
    Prediction of new onset of resting pulmonary arterial hypertension in systemic sclerosis.
    Arch Cardiovasc Dis. 2016;109:268-77.
    Abstract    

    Abstract available

  148. HASEGAWA M
    Biomarkers in systemic sclerosis: Their potential to predict clinical courses.
    J Dermatol. 2016;43:29-38.
    Abstract    

    Abstract available

  149. COYLE K, Coyle D, Blouin J, Lee K, et al
    Cost Effectiveness of First-Line Oral Therapies for Pulmonary Arterial Hypertension: A Modelling Study.
    Pharmacoeconomics. 2016;34:509-20.
    Abstract    

    Abstract available

  150. HE WX, Yang YL, Xia Y, Song N, et al
    Outcomes of Chinese Patients with End-stage Pulmonary Disease while Awaiting Lung Transplantation: A Single-center Study.
    Chin Med J (Engl). 2016;129:3-7.
    Abstract    

    Abstract available

  151. SAHNI S, Ojrzanowski M, Majewski S, Talwar A, et al
    Pulmonary arterial hypertension: a current review of pharmacological management.
    Pneumonol Alergol Pol. 2016;84:47-61.
    Abstract    

    Abstract available

  152. GIEN J, Kinsella JP
    Differences in preductal and postductal arterial blood gas measurements in infants with severe congenital diaphragmatic hernia.
    Arch Dis Child Fetal Neonatal Ed. 2016;101:F314-8.
    Abstract    

    Abstract available

  153. CAMERON DM, McLaughlin VV, Rubenfire M, Visovatti S, et al
    Usefulness of Echocardiography/Doppler to Reliably Predict Elevated Left Ventricular End-Diastolic Pressure in Patients With Pulmonary Hypertension.
    Am J Cardiol. 2016 Dec 2. pii: S0002-9149(16)31885.
    Abstract    

    Abstract available

  154. GLADWIN MT
    Translational Advances in the Field of Pulmonary Hypertension Bench to Bedside: How Fundamental Discoveries in Science Are Advancing Our Understanding and Therapy of Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2017;195:1-3.
    Abstract    



  155. LOUP O, Wustmann K, Martinelli MV, Schwerzmann M, et al
    Failing Systemic Right Ventricles With Persistent Pulmonary Hypertension: Candidates for Ventricular Assist Devices as Destination Therapy?
    Ann Thorac Surg. 2017;103:e179-e181.
    Abstract    

    Abstract available

  156. ZUCKER MJ
    Point: Should wireless pulmonary artery hemodynamic monitoring be used to monitor patients with pulmonary hypertension? YES.
    Chest. 2016 Dec 22. pii: S0012-3692(16)62632-6. doi: 10.1016/j.chest.2016.
    Abstract    



  157. HEMNES AR
    Counterpoint: Should wireless pulmonary artery hemodynamic monitoring be used to monitor patients with pulmonary hypertension? No.
    Chest. 2016 Dec 22. pii: S0012-3692(16)62629-6. doi: 10.1016/j.chest.2016.
    Abstract    



  158. HSU S, Houston BA, Tampakakis E, Bacher AC, et al
    Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension.
    Circulation. 2016 May 11. pii: CIRCULATIONAHA.116.022082.
    Abstract    

    Abstract available

  159. DAI Z, Li M, Wharton J, Zhu MM, et al
    PHD2 Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans through HIF-2alpha.
    Circulation. 2016 Apr 25. pii: CIRCULATIONAHA.116.021494.
    Abstract    

    Abstract available

  160. RAEISI-GIGLOU P, Lam L, Tamarappoo BK, Newman J, et al
    Evaluation of left ventricular diastolic function profile in patients with pulmonary hypertension due to heart failure with preserved ejection fraction.
    Clin Cardiol. 2016 Dec 27. doi: 10.1002/clc.22664.
    Abstract    

    Abstract available

  161. LATSHANG TD, Furian M, Aeschbacher SS, Ulrich S, et al
    Association between sleep apnoea and pulmonary hypertension in Kyrgyz highlanders.
    Eur Respir J. 2016 Dec 22. pii: 1601530. doi: 10.1183/13993003.01530-2016.
    Abstract    

    Abstract available

  162. SOMMER N, Strielkov I, Pak O, Weissmann N, et al
    Oxygen sensing and signal transduction in hypoxic pulmonary vasoconstriction.
    Eur Respir J. 2016;47:288-303.
    Abstract    

    Abstract available

  163. KIM NH, D'Armini AM, Grimminger F, Grunig E, et al
    Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.
    Heart. 2016 Dec 23. pii: heartjnl-2016-309621. doi: 10.1136/heartjnl-2016-309621
    Abstract    

    Abstract available

  164. VONK NOORDEGRAAF A, Westerhof BE, Westerhof N
    The Relationship Between the Right Ventricle and its Load in Pulmonary Hypertension.
    J Am Coll Cardiol. 2017;69:236-243.
    Abstract    

    Abstract available

  165. AKAGI S, Nakamura K, Matsubara H, Kondo M, et al
    Intratracheal administration of prostacyclin analog-incorporated nanoparticles ameliorates the development of monocrotaline and sugen/hypoxia-induced pulmonary arterial hypertension.
    J Cardiovasc Pharmacol. 2016.
    Abstract    

    Abstract available

  166. ROLDAN T, Landzberg MJ, Deicicchi DJ, Atay JK, et al
    Anticoagulation in patients with pulmonary arterial hypertension: An update on current knowledge.
    J Heart Lung Transplant. 2016;35:151-64.
    Abstract    

    Abstract available

  167. VAN DER FEEN DE, Dickinson MG, Bartelds B, Borgdorff MA, et al
    Egr-1 identifies neointimal remodeling and relates to progression in human pulmonary arterial hypertension.
    J Heart Lung Transplant. 2016;35:481-90.
    Abstract    

    Abstract available

  168. AL-GHANEM G, Shah P, Thomas S, Banfield L, et al
    Bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis.
    J Perinatol. 2017 Jan 12. doi: 10.1038/jp.2016.
    Abstract    

    Abstract available

  169. KOVACS G, Avian A, Foris V, Tscherner M, et al
    Use of ECG and Other Simple Non-Invasive Tools to Assess Pulmonary Hypertension.
    PLoS One. 2016;11:e0168706.
    Abstract    

    Abstract available

  170. WANG L, Qu M, Chen Y, Zhou Y, et al
    Statins Have No Additional Benefit for Pulmonary Hypertension: A Meta-Analysis of Randomized Controlled Trials.
    PLoS One. 2016;11:e0168101.
    Abstract    

    Abstract available

  171. GOTTING M, Schwarzer M, Gerber A, Klingelhofer D, et al
    Pulmonary Hypertension: Scientometric Analysis and Density-Equalizing Mapping.
    PLoS One. 2017;12:e0169238.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;